The ATRI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ATRI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ATRI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ATRI Detailed Price Forecast - CNN Money||View ATRI Detailed Summary - Google Finance|
|View ATRI Detailed Summary - Yahoo! Finance||View ATRI Stock Research & Analysis - Zacks.com|
|View ATRI Trends & Analysis - Trade-Ideas||View ATRI Major Holders - Barrons|
|View ATRI Call Transcripts - NASDAQ||View ATRI Breaking News & Analysis - Seeking Alpha|
|View ATRI Annual Report - CompanySpotlight.com||View ATRI OTC Short Report - OTCShortReport.com|
|View ATRI Fundamentals - TradeKing||View ATRI SEC Filings - Bar Chart|
|View Historical Prices for ATRI - The WSJ||View Performance/Total Return for ATRI - Morningstar|
|View the Analyst Estimates for ATRI - MarketWatch||View the Earnings History for ATRI - CNBC|
|View the ATRI Earnings - StockMarketWatch||View ATRI Buy or Sell Recommendations - MacroAxis|
|View the ATRI Bullish Patterns - American Bulls||View ATRI Short Pain Metrics - ShortPainBot.com|
|View ATRI Stock Mentions - StockTwits||View ATRI Stock Mentions - PennyStockTweets|
|View ATRI Stock Mentions - Twitter||View ATRI Investment Forum News - Investor Hub|
|View ATRI Stock Mentions - Yahoo! Message Board||View ATRI Stock Mentions - Seeking Alpha|
|View Insider Transactions for ATRI - SECform4.com||View Insider Transactions for ATRI - Insider Cow|
|View ATRI Major Holdings Summary - CNBC||View Insider Disclosure for ATRI - OTC Markets|
|View Insider Transactions for ATRI - Yahoo! Finance||View Institutional Holdings for ATRI - NASDAQ|
|View ATRI Stock Insight & Charts - FinViz.com||View ATRI Investment Charts - StockCharts.com|
|View ATRI Stock Overview & Charts - BarChart||View ATRI User Generated Charts - Trading View|
Blog Exposure - FDA Approved Expanded Indications for TransEnterix's Senhance Surgical System
Posted on Thursday May 31, 2018
LONDON, UK / ACCESSWIRE / May 31, 2018 / If you want access to our free research report on TransEnterix, Inc. (NYSE: TRXC), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=TRXC as the Company's latest news hit the wire. On May 29, 2018, the Company announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for expanded indications of the Company's Senhance Surgical System for laparoscopic inguinal hernia and laparoscopic cholecystectomy (gallbladder removal) surgery.
New Research: Key Drivers of Growth for CSW Industrials, Cavco Industries, Intra-Cellular Therapies, Atrion, QAD, and A V Homes — Factors of Influence, Major Initiatives and Sustained Production
Posted on Thursday May 24, 2018
NEW YORK, May 24, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of CSW ...
Atrion Corporation Declares Quarterly Cash Dividend
Posted on Tuesday May 22, 2018
ALLEN, Texas, May 22, 2018-- Atrion Corporation today announced that its Board of Directors declared a quarterly dividend of $1.20 per share on its outstanding shares of Common Stock. This dividend will ...
Atrion: 1Q Earnings Snapshot
Posted on Thursday May 10, 2018
The Allen, Texas-based company said it had net income of $4.57 per share. Earnings, adjusted for pretax gains, were $4.56 per share. The medical device maker posted revenue of $39.4 million in the period. ...